7,295 results match your criteria Gynecologic Tumor Markers


Serum folate receptor α (sFR) in ovarian cancer diagnosis and surveillance.

Cancer Med 2019 Feb 13. Epub 2019 Feb 13.

Department of Oncology, Division of Gynecologic Oncology, Wayne State University and Karmanos Cancer Institute, Detroit, Michigan.

Novelty and Impact Statement: Our findings suggest that soluble folate receptor (sFR) could be used in both the initial diagnosis and surveillance of patients with ovarian cancer. Our cohort constitutes one of the largest comparison groups for sFR analyzed so far. We have defined the background level of sFR using healthy volunteers. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.1944DOI Listing
February 2019
1 Read

Can complete blood count inflammatory parameters in epithelial ovarian cancer contribute to prognosis? - a survival analysis.

J Ovarian Res 2019 Feb 11;12(1):16. Epub 2019 Feb 11.

Department of Gynecologic Oncology, Zekai Tahir Burak Women's Health, Education and Research Hospital, Ankara, Turkey.

Subjective: The aim of the present study was to investigate the prognostic significance of preoperative complete blood count inflammatory markers in women operated for invasive Epithelial Ovarian Cancer (EOC).

Method: Two hundred forty four patients that underwent operation with the diagnosis of invasive EOC between 2006 and 2014 were included in the study. The date of operation, date of recurrence and final mortality evaluations were performed for survival analysis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13048-019-0491-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371536PMC
February 2019
1 Read

Abundance of mitochondrial superoxide dismutase is a negative predictive biomarker for endometriosis-associated ovarian cancers.

World J Surg Oncol 2019 Jan 30;17(1):24. Epub 2019 Jan 30.

Department of Obstetrics and Gynecology, Shiga University of Medical Science, SetaTsukinowa-cho, Otsu, Shiga, 520-2192, Japan.

Background: Endometrioid ovarian carcinoma and clear cell ovarian carcinoma are both classified as endometriosis-associated ovarian cancers (EAOCs). Despite the high rates of recurrence and mortality of EAOC, only a few prognostic biomarkers have been reported. Mitochondrial superoxide dismutase (SOD2) plays an important role in maintaining mitochondrial function through oxidative stress tolerance and contributes to chemotherapeutic resistance. Read More

View Article

Download full-text PDF

Source
https://wjso.biomedcentral.com/articles/10.1186/s12957-019-1
Publisher Site
http://dx.doi.org/10.1186/s12957-019-1565-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354361PMC
January 2019
2 Reads

Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells.

Cancers (Basel) 2019 Jan 27;11(2). Epub 2019 Jan 27.

Department of Biochemistry and Molecular Biology, Medical University of Lublin, Chodzki 1 St., 20-093 Lublin, Poland.

Histone deacetylase inhibitors (HDIs) are a group of potent epigenetic drugs which have been investigated for their therapeutic potential in various clinical disorders, including hematological malignancies and solid tumors. Currently, several HDIs are already in clinical use and many more are on clinical trials. HDIs have shown efficacy to inhibit initiation and progression of cancer cells. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11020148DOI Listing
January 2019
2 Reads

Reviewing vulvar Paget's disease molecular bases. Looking forward to personalized target therapies: a matter of CHANGE.

Int J Gynecol Cancer 2019 Jan 23. Epub 2019 Jan 23.

Division of Gynecologic Oncology, Vul.Can MDT, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.

Objectives: To review the published literature on vulvar Paget's disease (VPD) molecular bases, aiming to support the need for tailored treatment in women affected by this 'orphan' tumor.

Methods: MEDLINE-PubMed and Scopus were interrogated using the following algorithm: (extramammary OR extra mammary OR vulvar) AND (paget OR pagets OR paget's) AND (molecular OR biological OR marker OR protein OR target OR expression). The inclusion criteria for papers were: peer-reviewed English-language journals, articles published in the last 30 years, studies focused on fixed research questions, quality assessment on the basis of the relevance and contribution to the selected topics. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ijgc-2018-000080DOI Listing
January 2019
2 Reads

Brain metastasis from ovarian clear cell carcinoma: A case report.

Medicine (Baltimore) 2019 Jan;98(3):e14020

Department of Oncology, Xiang Ya Hospital, Central South University, China.

Rationale: Epithelial ovarian carcinoma (EOC) is the most common type of ovarian carcinoma, and the leading cause of female genital tract cancer-related deaths. However, brain metastasis (BM) of EOC is rare, with an incidence of only 1% to 2%. Ovarian clear cell carcinoma (OCCC), accounting for 5% to 25% of all EOC cases, has a poor prognosis compared with other epithelial cell type carcinomas. Read More

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00005792-201901180-0002
Publisher Site
http://dx.doi.org/10.1097/MD.0000000000014020DOI Listing
January 2019
4 Reads

Silver Nanoparticles Potentiates Cytotoxicity and Apoptotic Potential of Camptothecin in Human Cervical Cancer Cells.

Oxid Med Cell Longev 2018 12;2018:6121328. Epub 2018 Dec 12.

Division of Applied Life Science (BK21 Plus), Institute of Agriculture and Life Science, Gyeongsang National University, Jinju 52828, Gyeongnam Province, Republic of Korea.

Silver nanoparticles (AgNPs) are widely used metal nanoparticles in health care industries, particularly due to its unique physical, chemical, optical, and biological properties. It is used as an antibacterial, antiviral, antifungal, and anticancer agent. Camptothecin (CPT) and its derivatives function as inhibitors of topoisomerase and as potent anticancer agents against a variety of cancers. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2018/6121328DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311846PMC
February 2019

Combination of Proteasome and Histone Deacetylase Inhibitors Overcomes the Impact of Gain-of-Function p53 Mutations.

Dis Markers 2018 17;2018:3810108. Epub 2018 Dec 17.

Department of Obstetrics and Gynecology, University of Iowa, Iowa City, Iowa 52242, USA.

Mutations in the "guardian of the genome" predominate in solid tumors. In addition to loss of tumor suppressor activity, a specific subset of missense mutations confers additional oncogenic properties. These "gain-of-function" (GOF) mutations portend poor prognosis across cancer types regardless of treatment. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2018/3810108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311857PMC
December 2018
1 Read

Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target.

Cancer Cell Int 2019 8;19:10. Epub 2019 Jan 8.

1Obstetrics and Gynecology, University of British Columbia, Vancouver, BC Canada.

Background: Although low-grade serous ovarian cancer (LGSC) is rare, case-fatality rates are high as most patients present with advanced disease and current cytotoxic therapies are not overly effective. Recognizing that these cancers may be driven by MAPK pathway activation, MEK inhibitors (MEKi) are being tested in clinical trials. LGSC respond to MEKi only in a subgroup of patients, so predictive biomarkers and better therapies will be needed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12935-019-0725-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325847PMC
January 2019
2 Reads

Proteomic pattern of cervico-vaginal fluid (CVF) in an ovarian cancer diagnosis - pilot study.

Ginekol Pol 2018 ;89(12):688-694

Department of Gynecology, Obstetrics and Gynecologic Oncology, Division of Gynecologic Oncology, Poznan University of Medical Sciences, Poznan, Polska.

Objectives: High grade serous ovarian cancer (HGSC) is the most common type of ovarian cancer and is responsible for about 90% of ovarian cancer deaths. The diagnostic tests currently used do not increase the detection rates for ovarian cancer. There is a great necessity to develop new and non-invasive diagnostic tests for ovarian cancer (OC). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/GP.a2018.0116DOI Listing
January 2018
4 Reads

Expression of toll-like receptors in ovarian cancer.

J BUON 2018 Nov-Dec;23(6):1725-1731

"Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Purpose: Ovarian cancer continues to be the most lethal gynecologic malignancy, with a complex tumor microenvironment (TME). We investigated the immunohistochemical (IHC) expression of toll like receptors (TLRs) 4,5,7 and 9 together with CD68 and CD 163 as markers for tumor-associated macrophages (TAM) in relation to clinicopathological data.

Methods: Data from 102 patients with serous ovarian cancer treated between 2006 and 2011 was retrospectively reviewed. Read More

View Article

Download full-text PDF

Source
January 2019
8 Reads

Cisplatin-induced cardiotoxicity with midrange ejection fraction: A case report and review of the literature.

Medicine (Baltimore) 2018 Dec;97(52):e13807

Department of Cardiology, Peking Union Medical College Hospital, Beijing, China.

Rationale: Cisplatin monotherapy-induced cardiotoxicity is rare, and the prevalence remains unknown. It's extremely important to stop cisplatin when cardiotoxicity is considered.

Patient Concerns: A 53-year-old woman developed cervical cancer. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000013807DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314747PMC
December 2018
1 Read

Probing pathway-related modules in invasive squamous cervical cancer based on topological centrality of network strategy.

J Cancer Res Ther 2018 ;14(7):1638-1643

Department of Gynecology and Obstetrics, Jinan Maternity and Child Care Hospital, Jinan 250001, P.R. China.

Objective: Our work aimed to identify pathway-related modules and hub genes involved in invasive squamous cervical cancer (SCC) based on topological centralities analysis of networks.

Materials And Methods: To determine the functional modules changed in SCC, functional enrichment analyses were performed for differentially expressed genes (DEGs) between invasive SCC samples and normal controls. Then, co-expression network was constructed using EBcoexpress approach based on the DEGs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0973-1482.187352DOI Listing
February 2019

Oncological markers CA-125, CA 19-9 and endometriosis.

Medicine (Baltimore) 2018 Dec;97(51):e13759

Department of Psychiatry, First Faculty of Medicine, Charles University, Prague.

The endometrium tissue is functionally androgen related which plays an important role in women's fertility regulation. In addition recent findings show that endometrium related pathology is closely linked to disrupted androgen biosynthesis and associated regulatory functions. These findings also suggest that androgens might play an important role in endometrium related cancer pathology with significant implications for treatment. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000013759DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320090PMC
December 2018
1 Read

HLA class II expression on tumor cells and low numbers of tumor-associated macrophages predict clinical outcome in oropharyngeal cancer.

Head Neck 2019 Feb 14;41(2):463-478. Epub 2018 Dec 14.

Division of Medical Oncology, Antoni van Leeuwenhoek, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Background: Human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma (OPSCC) is a highly immunogenic tumor and differences in tumor microenvironment might contribute to the improved survival of HPV-positive OPSCC patient.

Methods: A comprehensive multivariate analysis with clinical and immune variables (human leukocyte antigen [HLA] I/II, programmed death ligand 1 (PD-L1), programmed death receptor 1 (PD1), T cells, and macrophages) was performed in 142 OPSCC patients.

Results: We found an inverse correlation between the expression of HLA class II molecules on tumor cells and CD68+ CD163+ tumor-associated macrophages (TAMs). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.25442DOI Listing
February 2019
1 Read

Molecular subtype not immune response drives outcomes in endometrial carcinoma.

Clin Cancer Res 2018 Dec 6. Epub 2018 Dec 6.

Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, University of British Columbia

Purpose: Tumors with high mutation load are thought to engender stronger immune responses which in turn promote prolonged patient survival. To investigate this, we assessed tumor-infiltrating lymphocytes (TIL) and immunosuppressive factors across the four molecular subtypes of endometrial cancer (EC), which have characteristic mutation rates ranging from low to ultra-high.

Experimental Design: 460 ECs were stratified by ProMisE (Proactive Molecular Risk Classifier in Endometrial cancer) into four molecular subtypes: mismatch repair-deficient (MMRd), POLE mutant (POLE), p53 abnormal (p53abn), and p53 wildtype (p53wt). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-3241DOI Listing
December 2018
7 Reads

Transdifferentiations and heterogeneity in the stromal niches of uterine leiomyomas.

Rom J Morphol Embryol 2018 ;59(3):663-672

Division of Anatomy, Department 1, Faculty of Dental Medicine, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania;

Uterine leiomyomas, also known as uterine fibroids (UFs), are benign smooth muscle cells tumors, the most frequent tumors in women. Even though UFs are monoclonal tumors, they contain a heterogeneous and versatile cells population. There are scarce proofs about the processes of transdifferentiation that might occur in UFs, modify the tumor microenvironment and support blood and lymph vessels formation. Read More

View Article

Download full-text PDF

Source
December 2018
2 Reads

STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway.

J Exp Clin Cancer Res 2018 Dec 5;37(1):305. Epub 2018 Dec 5.

Department of Gynecologic Oncology; Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, 310006, China.

Background: Cancer stem cells (CSCs) possess abilities of self-renewal and differentiation, have oncogenic potential and are regarded to be the source of cancer recurrence. However, the mechanism by which CSCs maintain their stemness remains largely unclear.

Methods: In this study, the cell line-derived ovarian CSCs (OCSCs), 3AO and Caov3, were enriched in serum-free medium (SFM). Read More

View Article

Download full-text PDF

Source
https://jeccr.biomedcentral.com/articles/10.1186/s13046-018-
Publisher Site
http://dx.doi.org/10.1186/s13046-018-0977-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282299PMC
December 2018
10 Reads

Expression of CK7 and CDKN2 in Cervical Intraepithelial Neoplasia and Correlation with Clinical Outcome.

Anticancer Res 2018 Dec;38(12):6673-6681

Gynecological Disease Prevention Nucleus (NUPREV), Department of Gynecology, Federal University of São Paulo, Sao Paulo, Brazil.

Aim: To evaluate cyclin-dependent kinase inhibitor 2A (CDKN2A) and cytokeratin 7 (CK7) expression in cervical intraepithelial neoplasia (CIN) formalin-fixed samples.

Materials And Methods: Staining with antibody clones G175-405 for CDKN2A and OV-TL 12/30 for CK7 were evaluated and the detection of protein expressions were compared in 147 patients with CIN.

Results: Clinical follow-up of patients with CIN1 and CIN2 showed that most patients had a favorable outcome. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.13035DOI Listing
December 2018
1 Read

The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trial.

J Bone Oncol 2019 Feb 2;14:010-10. Epub 2018 Oct 2.

Department of Oncology, Bethanien Hospital, Frankfurt am Main, Germany.

Background: Breast cancer and its treatments are associated with a detrimental effect on bone health. Here we report the results of an exploratory analysis assessing changes in levels of biomarkers of bone metabolism in patients enrolled in the phase IIIb 4EVER study.

Methods: The 4EVER trial investigated everolimus in combination with exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbo.2018.09.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263089PMC
February 2019
4 Reads

Management of placental site trophoblastic tumor: Two case reports.

Medicine (Baltimore) 2018 Nov;97(48):e13439

Interdisciplinary Department of Medicine, Gynecology and Obstetrics Clinic, University of Bari.

Rationale: Placental site trophoblastic tumor (PSTT) is a very rare malignant tumor, belonging to a family of pregnancy-related illnesses, called gestational trophoblastic diseases (GTD). Less than 300 cases of PSTT have been reported in literature, with an incidence of ≈ 1/50,000-100,000 pregnancies representing only 0.23% to 3. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000013439DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283185PMC
November 2018
13 Reads

Primary squamous cell carcinoma of the endometrium in a woman of perimenopausal age: A case report.

Medicine (Baltimore) 2018 Nov;97(48):e13418

Department of Gynecology.

Rationale: Primary squamous cell carcinoma of the endometrium (PSCCE) is a rare entity, and only sporadic cases have been reported in the literature since the 1st report in 1892. This report describes a case of a perimenopausal woman with PSCCE.

Patient Concerns: A 47-year-old, human papilloma virus type 16-positive, perimenopausal woman was admitted to our hospital with irregular vaginal bleeding for 6 months and secondary anemia. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000013418DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283105PMC
November 2018
2 Reads
5.723 Impact Factor

FDG PET/CT as a survival prognostic factor in patients with advanced renal cell carcinoma.

Clin Exp Med 2019 Feb 28;19(1):143-148. Epub 2018 Nov 28.

Department of Oncology, Radiotherapy and Gynecologic Oncology, Faculty of Health Sciences, Nicolaus Copernicus University, Collegium Medicum, Bydgoszcz, Poland.

Accurate prediction of the outcome of molecular target-based treatment in advanced renal cell carcinoma (RCC) is an important clinical problem. Positron emission tomography/computed tomography using [18F]-2-fluoro-2-deoxyglucose (FDG PET/CT) is a noninvasive tool for the assessment of glucose accumulation which can be a marker of the biological characteristics of the tumor. In this paper, we assess FDG PET/CT as a survival prognostic marker in patients with advanced RCC. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10238-018-0539-9
Publisher Site
http://dx.doi.org/10.1007/s10238-018-0539-9DOI Listing
February 2019
11 Reads

Expression Profile of Endoglin in Different Grades of Endometrial Cancer.

Curr Pharm Biotechnol 2018 ;19(12):990-995

Department of Gynecology and Obstetrics with Gynecologic Oncology, Ludwik Rydygier Memorial Specialist Hospital, Krakow, Poland.

Background: Endoglin is a marker of active, proliferating endothelial cells of blood vessels. In many cancers, it is present in both peripheral vessels and vessels located inside the tumor. Endoglin is more specific and sensitive compared to other tumor angiogenesis markers. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1389201020666181127152605DOI Listing
January 2018
9 Reads

Identification and validation of potential prognostic and predictive miRNAs of epithelial ovarian cancer.

PLoS One 2018 26;13(11):e0207319. Epub 2018 Nov 26.

Department of Pathology, Molecular unit, Danish CancerBiobank, Herlev University Hospital, Herlev, Denmark.

Background: Ovarian cancer is the leading cause of death by gynecologic cancers in the Western world. The aim of the study was to identify microRNAs (miRNAs) associated with prognosis and/or resistance to chemotherapy among patients with epithelial ovarian cancer.

Methods: Using information from the Pelvic Mass Study we identified a cohort of women with epithelial ovarian cancer. Read More

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0207319PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261038PMC
November 2018
2 Reads

A prospective cohort study to evaluate immunosuppressive cytokines as predictors of viral persistence and progression to pre-malignant lesion in the cervix in women infected with HR-HPV: study protocol.

BMC Infect Dis 2018 Nov 19;18(1):582. Epub 2018 Nov 19.

Chronic Infectious Diseases and Cancer Division, Center for Research on Infectious Diseases, Instituto Nacional de Salud Pública (INSP), Cuernavaca, Morelos, Mexico.

Background: Cervical cancer (CC) is caused by a persistent infection of high-risk human papillomavirus (HR-HPV). While most HPV infections are transient, persistent HPV infections are a significant health problem in Mexico. With an estimated HPV prevalence of 10% among women in reproductive age, approximately 25% of these women present at least a positive result in triage test, which according to previous studies is expected to be confirmed as positive CIN-2/3. Read More

View Article

Download full-text PDF

Source
https://bmcinfectdis.biomedcentral.com/articles/10.1186/s128
Publisher Site
http://dx.doi.org/10.1186/s12879-018-3490-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245844PMC
November 2018
9 Reads

Genome-wide characterization of aberrant DNA methylation patterns and the potential clinical implications in patients with endometrial cancer.

Pathol Res Pract 2019 Jan 11;215(1):137-143. Epub 2018 Nov 11.

Department of Gynecology, The Affiliated Tumor Hospital, Harbin Medical University, 150081 Harbin, China. Electronic address:

Aberrant DNA methylation has been implicated in the development of the majority of human cancers. However, the association of aberrant DNA methylation with the clinical characteristics of uterine corpus endometrial carcinoma (UCEC) has not been fully explored. We performed an integrative analysis in order to examine the genome-wide DNA methylation profile and the gene expression profile of 432 UCEC samples and 46 normal tissue samples. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prp.2018.11.002DOI Listing
January 2019

Breast metastasis two years after pelvic surgery and adjuvant chemotherapy for serous ovarian cancer.

Gynecol Endocrinol 2018 Nov 19:1-3. Epub 2018 Nov 19.

a Department of Neuroscience, Reproductive Sciences and Dentistry , University of Naples Federico II , Naples , Italy.

Ovarian cancer is considered the leading cause of death among gynecologic neoplasias. Breast metastases from primary ovarian cancer have been reported in only 0.03-0. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/09513590.2018.1521795DOI Listing
November 2018
10 Reads

Prognostic significance of Ki-67 levels and hormone receptor expression in low-grade serous ovarian carcinoma: an investigation of the tumor bank ovarian cancer network.

Hum Pathol 2018 Nov 11. Epub 2018 Nov 11.

Department of Gynecology, Charité University Hospital, Berlin, Germany; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung, Essen, Germany.

Low-grade serous ovarian carcinoma (LGSOC) has recently come up as a distinct rare entity of epithelial ovarian cancer. Predictive and prognostic markers are not well studied yet. As Ki-67 and hormone receptors (HR) has been established as relevant cancer biomarkers in several malignant tumors we evaluated Ki-67 and HR expression rates by immunohistochemistry in 68 patients with LGSOC. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00468177183041
Publisher Site
http://dx.doi.org/10.1016/j.humpath.2018.10.020DOI Listing
November 2018
22 Reads

Length Scale Matters: Real-Time Elastography versus Nanomechanical Profiling by Atomic Force Microscopy for the Diagnosis of Breast Lesions.

Biomed Res Int 2018 16;2018:3840597. Epub 2018 Oct 16.

Gynecology and Gynecologic Oncology, Claraspital, 4016 Basel, Switzerland.

Real-time elastography (RTE) is a noninvasive imaging modality where tumor-associated changes in tissue architecture are recognized as increased stiffness of the lesion compared to surrounding normal tissue. In contrast to this macroscopic appraisal, quantifying stiffness properties at the subcellular level by atomic force microscopy (AFM) reveals aggressive cancer cells to be soft. We compared RTE and AFM profiling of the same breast lesion to explore the diagnostic potential of tissue elasticity at different length scales. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2018/3840597DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206582PMC
February 2019
3 Reads

Estrogen Receptors alpha and beta in Ovarian Cancer: Expression Level and Prognosis.

Dokl Biochem Biophys 2018 Sep 5;482(1):249-251. Epub 2018 Nov 5.

Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia.

The quantitative immunofluorescence assay of serous ovarian cancer tissue for the expression of estrogen receptors (ERα and ERβ) revealed a higher expression level of ERβ in comparison with ERα in all surgical tumor samples investigated. Significant differences in the expression level of the markers were detected "from tumor to tumor." A high expression level of both ERα (≥ 25%) and ERβ (≥ 44%) in the tumor predicts a significantly longer progression-free survival time (p < 0. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1134/S1607672918050058
Publisher Site
http://dx.doi.org/10.1134/S1607672918050058DOI Listing
September 2018
7 Reads

HPV16 viral characteristics in primary, recurrent and metastatic vulvar carcinoma.

Papillomavirus Res 2018 12 2;6:63-69. Epub 2018 Nov 2.

Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, SE-701 82 Örebro, Sweden.

Vulvar carcinoma is the fourth most common gynecological malignancy. Two separate carcinogenic pathways are suggested, where one is associated with the human papillomavirus (HPV) and HPV16 the most common genotype. The aim of this study was to evaluate HPV-markers in a set of primary tumors, metastases and recurrent lesions of vulvar squamous cell carcinomas (VSCC). Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S24058521183004
Publisher Site
http://dx.doi.org/10.1016/j.pvr.2018.10.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249404PMC
December 2018
8 Reads

Mass spectrometric discrimination of phospholipid patterns in cisplatin-resistant and -sensitive cancer cells.

Rapid Commun Mass Spectrom 2019 Jan;33(1):97-106

Dipartimento di Scienze Chimiche e Geologiche, University of Cagliari, Cagliari, Italy.

Rationale: Development of therapy-resistant cancer is a major problem in clinical oncology, and there is an urgent need for novel markers identifying development of the resistant phenotype. Lipidomics represents a promising approach to discriminate lipid profiles of malignant phenotype cells. Alterations in phospholipid distribution or chemical composition have been reported in various pathologies including cancer. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/rcm.8320
Publisher Site
http://dx.doi.org/10.1002/rcm.8320DOI Listing
January 2019
13 Reads

The associations between serum vascular endothelial growth factor, tumor necrosis factor and interleukin 4 with the markers of blood-brain barrier breakdown in patients with paraneoplastic neurological syndromes.

J Neural Transm (Vienna) 2019 Feb 29;126(2):149-158. Epub 2018 Oct 29.

Department of Neurology, Poznan University of Medical Sciences, Poznan, Poland.

The blood-brain barrier (BBB) disruption is a critical step in paraneoplastic neurological syndrome (PNS) development. Several cytokines have been implicated in BBB breakdown. However, the exact step-by-step mechanism in which PNS develops is unknown, and the relationship between a systemic neoplasm and BBB is multilevel. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00702-018-1950-9DOI Listing
February 2019
3 Reads

HPV16-Related Cervical Cancers and Precancers Have Increased Levels of Host Cell DNA Methylation in Women Living with HIV.

Int J Mol Sci 2018 Oct 23;19(11). Epub 2018 Oct 23.

Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.

Data on human papillomavirus (HPV) type-specific cervical cancer risk in women living with human immunodeficiency virus (WLHIV) are needed to understand HPV⁻HIV interaction and to inform prevention programs for this population. We assessed high-risk HPV type-specific prevalence in cervical samples from 463 WLHIV from South Africa with different underlying, histologically confirmed stages of cervical disease. Secondly, we investigated DNA hypermethylation of host cell genes , , and , as markers of advanced cervical disease, in relation to type-specific HPV infection. Read More

View Article

Download full-text PDF

Source
http://www.mdpi.com/1422-0067/19/11/3297
Publisher Site
http://dx.doi.org/10.3390/ijms19113297DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274896PMC
October 2018
4 Reads

PROLIFERATIVE/STEM CELL INDEX AND PHENOTYPIC CHARACTERISTICS OF PROLIFERATIVE PROCESSES IN ENDOMETRIUM.

Georgian Med News 2018 Sep(282):156-161

Tbilisi State Medical University, Georgia.

The aim of the study was to explore and identify the relationship between endometrial proliferative/stem cell index and phenotypic characteristics under proliferative processes of endometrium using statistical correlation analysis. The study represents a retrospective research. The coded and depersonalized material data from Acad. Read More

View Article

Download full-text PDF

Source
September 2018
2 Reads

Calcium Phosphate Cement Paste Injection as a Fiducial Marker of Cervical Cancer.

In Vivo 2018 Nov-Dec;32(6):1609-1615

Division of Radiation Oncology, Department of Oncology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Background/aim: Calcium phosphate cement (CPC) is used to fill bone voids in dental, orthopedic, and craniofacial applications. This study evaluated CPC marker as an injectable non-metallic fiducial marker.

Materials And Methods: Six patients received 3-5 injections of CPC paste placed at a depth of 10 mm into tumors of the cervix before treatment planning CT (TPCT). Read More

View Article

Download full-text PDF

Source
http://iv.iiarjournals.org/lookup/doi/10.21873/invivo.11421
Publisher Site
http://dx.doi.org/10.21873/invivo.11421DOI Listing
January 2019
12 Reads

Preserved miR-361-3p Expression Is an Independent Prognostic Indicator of Favorable Survival in Cervical Cancer.

Dis Markers 2018 23;2018:8949606. Epub 2018 Sep 23.

Department of Obstetrics & Gynecology, Cangzhou Central Hospital, Hebei 061001, China.

In this study, we aimed to assess the independent prognostic value of miR-361-3p in terms of overall survival (OS) and recurrence-free survival (RFS) in cervical cancer, as well as its possible regulative network. A retrospective analysis was performed by using data from the Cancer Genome Atlas-Cervical Cancer (TCGA-CESC). Results showed that decreased miR-361-3p expression was associated with lymphovascular invasion and poor responses to primary therapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2018/8949606DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174793PMC
January 2019
2 Reads
2.174 Impact Factor

Estrogen receptor β is associated with expression of cancer associated genes and survival in ovarian cancer.

BMC Cancer 2018 Oct 16;18(1):981. Epub 2018 Oct 16.

Department of Obstetrics and Gynecology, University Medical Center Regensburg, Landshuter Str. 65, 93053, Regensburg, Germany.

Background: In ovarian cancer, the role of estrogen receptors (ERs), particularly of ERβ, being suggested as tumor suppressor in breast and prostate cancer, remains unclear. We examined the expression of nuclear and cytoplasmic ERβ in ovarian cancer and correlated it with expression of ovarian cancer markers CA125, CEA and CA72-4, steroid hormone receptors ERα and PR, cancer-associated genes EGFR, p53, HER2 and proliferation marker Ki-67. Additionally we examined to what extent expression of ERβ and the other proteins affects survival of ovarian cancer patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-4898-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192185PMC
October 2018
3 Reads

Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.

Virchows Arch 2019 Jan 15;474(1):79-86. Epub 2018 Oct 15.

Department of Clinical Laboratory Sciences, School of Health Sciences, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.

Gastric-type adenocarcinoma (GA) is an aggressive subtype of cancer of the uterine cervix. Several immunohistochemical markers for gastric mucins, such as mucin 6 (MUC6) and N-acetylglucosamine α1 → 4galactose → R (αGlcNAc-R), which is recognized by HIK1083 antibody, have been introduced for diagnosis of GA and lobular endocervical glandular hyperplasia (LEGH). However, MUC6 is also expressed in normal endocervical glands and HIK1083 antibody has limited availability. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-018-2469-zDOI Listing
January 2019
4 Reads

Expression of programmed cell death ligand 1 and immune checkpoint markers in residual tumors after neoadjuvant chemotherapy for advanced high-grade serous ovarian cancer.

Gynecol Oncol 2018 12 9;151(3):414-421. Epub 2018 Oct 9.

Department of Obstetrics and Gynecology, Institute of Women's Life Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.

Objective: To investigate the prognostic value of the expressions of programmed cell death ligand 1 (PD-L1) and immune checkpoint markers in residual tumors after neoadjuvant chemotherapy (NAC) for advanced high-grade serous ovarian cancer (HGSOC).

Methods: We collected pre- and post-NAC tumor samples from patients with advanced HGSOC between 2006 and 2017. Post-NAC tumor tissue samples were available for immunostaining from 131 patients. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258183115
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2018.08.023DOI Listing
December 2018
10 Reads

A case of giant panda ovarian cancer diagnosis and histopathology.

BMC Vet Res 2018 Oct 12;14(1):311. Epub 2018 Oct 12.

Laboratory of Animal Disease Model, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, China.

Background: Ovarian cancer is diagnosed clinically by detecting ovarian cancer-related factors and markers. Here, we report a case of giant panda ovarian tumor metastasis with a combination of clinical and histopathological diagnosis.

Case Presentation: Histopathological studies revealed severe lesions and tumor cells in the ovaries, lungs, spleen, kidneys and perianal tissue. Read More

View Article

Download full-text PDF

Source
https://bmcvetres.biomedcentral.com/articles/10.1186/s12917-
Publisher Site
http://dx.doi.org/10.1186/s12917-018-1630-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186091PMC
October 2018
3 Reads

Normalization of abnormal plasma amino acid profile-based indexes in patients with gynecological malignant tumors after curative treatment.

BMC Cancer 2018 Oct 12;18(1):973. Epub 2018 Oct 12.

Department of Obstetrics and Gynecology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.

Background: We developed a novel plasma amino acid profile-based index (API) to detect ovarian, uterine, cervical, and endometrial cancers. In this study, we aimed to evaluate whether abnormal API values could be normalized after curative treatment in patients with gynecological malignant tumors.

Methods: Patients with gynecological cancer with abnormal API values were included in this study. Read More

View Article

Download full-text PDF

Source
https://bmccancer.biomedcentral.com/articles/10.1186/s12885-
Publisher Site
http://dx.doi.org/10.1186/s12885-018-4875-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186072PMC
October 2018
3 Reads

Cancer in pregnancy.

Int J Gynaecol Obstet 2018 Oct;143 Suppl 2:137-142

National Cancer Institute of Sri Lanka, Maharagama, Sri Lanka.

The incidence of cancer in pregnancy is increasing. The most frequent malignancies include breast and cervical cancers. Diagnosis may be complicated by late presentation. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijgo.12621
Publisher Site
http://dx.doi.org/10.1002/ijgo.12621DOI Listing
October 2018
12 Reads

[Research progression on triage of human papillomavirus positive women].

Zhonghua Zhong Liu Za Zhi 2018 Sep;40(9):641-646

Department of epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.

Persistently high risk human papillomavirus (HPV) infection is one of the indispensable factors of cervical cancer, which is the secondly most common cancer of women in developing countries. Nowadays HPV DNA detection has been more frequently used in cervical cancer initial screening. However, the specificity and sensitivity of HPV DNA detection are low and the triage of HPV positive women is necessary to identify the authentically high-risk population, and avoid the waste of health care resource and excessive treatment. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.0253-3766.2018.09.001DOI Listing
September 2018
10 Reads

Markers of the epithelial-mesenchymal transition in cells of endometrial carcinoma.

Exp Oncol 2018 Oct;40(3):218-222

R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine.

Aim: To study the expression of adhesion markers (E-cadherin, β-catenin and vimentin) associated with epithelial-mesenchymal transition (EMT) and their role in progression of endometrial carcinoma (EC).

Materials And Methods: Expression of E-cadherin, β-catenin and vimentin was studied immunohistochemically in the samples of surgical material of 55 EC patients stage I-III. The proliferation index was determined by flow cytometry. Read More

View Article

Download full-text PDF

Source
October 2018
9 Reads

[The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition].

Bull Cancer 2018 Oct 27;105(10):907-917. Epub 2018 Sep 27.

Institut Paoli-Calmettes, oncogénétique clinique, département d'anticipation et de suivi des cancers, 232, boulevard Sainte-Marguerite, 13009 Marseille, France; Aix-Marseille université, Inserm, IRD, SESSTIM, 13000 Marseille, France.

Introduction: Next generation sequencing allows the simultaneous analysis of large panel of genes for families or individuals with a strong suspicion of hereditary breast and/or ovarian cancer (HBOC). Because of lack of guidelines, several panels of genes potentially involved in HBOC were designed, with large disparities not only in their composition but also in medical care offered to mutation carriers. Then, homogenization in practices is needed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2018.08.003DOI Listing
October 2018
8 Reads

Molecular iodine inhibits the expression of stemness markers on cancer stem-like cells of established cell lines derived from cervical cancer.

BMC Cancer 2018 Sep 26;18(1):928. Epub 2018 Sep 26.

División de Investigación Básica, Laboratory of Virus and Cancer, Instituto Nacional de Cancerología, Secretaria de Salud, Av. San Fernando No. 22, Sección XVI, Tlalpan, 14080, Ciudad de México, CP, Mexico.

Background: Cancer stem cells (CSC) are characterized by deregulated self-renewal, tumorigenicity, metastatic potential, aberrant stemness signaling pathways, resistance to conventional therapy, and the ability to give rise to a progeny of proliferating cells that constitute the bulk of tumors. Targeting CSC will provide novel treatments for cancer. Different investigations have focused on developing complementary approaches that involve natural compounds that decrease chemo-resistance and reduce the side effects of conventional therapies. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-4824-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158890PMC
September 2018
3 Reads

Immunohistochemical Characterization Improves the Reproducibility of the Histological Diagnosis of Ovarian Carcinoma

Asian Pac J Cancer Prev 2018 Sep 26;19(9):2545-2551. Epub 2018 Sep 26.

Research Unit UR14ES17, Cancer Epidemiology and Cytopathology in Tunisian Center, Medicine Faculty of Sousse, University of Sousse, Tunisia.

Background: Ovarian cancer is the leading cause of gynecologic cancer-related death. Histological assessment remains the standard clue for the diagnosis of ovarian carcinoma. Misinterpretation and inconsistent application of histological criteria may lead to significant interobserver variability and poor reproducibility of the diagnosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.22034/APJCP.2018.19.9.2545DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249481PMC
September 2018
6 Reads
1.500 Impact Factor

Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening.

Int J Infect Dis 2019 Jan 21;78:22-30. Epub 2018 Sep 21.

Department of Pathology, Wonju College of Medicine, Yonsei University, Wonju, Republic of Korea.

Objectives: Pap smear and high-risk human papillomavirus (HR-HPV) DNA testing are the most widely applied methods for cervical cancer screening, but both methods are limited by their low specificity and lack of association with patient prognoses. The aim of this study was to compare the clinical and prognostic significance of HPV E6/E7 mRNA as an early biomarker with cytology and HPV DNA detection in cervical cancer screening.

Methods: This study evaluated the performance of the Optimygene HR-HPV RT-qDx assay, which is an HPV E6/E7 mRNA-based assay, to detect 16 HR-HPV subtypes: HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, and 69. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S12019712183452
Publisher Site
http://dx.doi.org/10.1016/j.ijid.2018.09.014DOI Listing
January 2019
3 Reads